|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4657760A
(en)
|
1979-03-20 |
1987-04-14 |
Ortho Pharmaceutical Corporation |
Methods and compositions using monoclonal antibody to human T cells
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4713339A
(en)
|
1983-01-19 |
1987-12-15 |
Genentech, Inc. |
Polycistronic expression vector construction
|
|
AU2353384A
(en)
|
1983-01-19 |
1984-07-26 |
Genentech Inc. |
Amplification in eukaryotic host cells
|
|
DD266710A3
(de)
|
1983-06-06 |
1989-04-12 |
Ve Forschungszentrum Biotechnologie |
Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
GB8430252D0
(en)
|
1984-11-30 |
1985-01-09 |
Beecham Group Plc |
Compounds
|
|
US5206344A
(en)
|
1985-06-26 |
1993-04-27 |
Cetus Oncology Corporation |
Interleukin-2 muteins and polymer conjugation thereof
|
|
DE3779221D1
(de)
|
1986-08-19 |
1992-06-25 |
Genentech Inc |
Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und -zytokinen.
|
|
JPH04501201A
(ja)
|
1987-12-21 |
1992-03-05 |
ジ・アップジョン・カンパニー |
発芽植物種子類のアグロバクテリウム媒介形質転換
|
|
US5166322A
(en)
|
1989-04-21 |
1992-11-24 |
Genetics Institute |
Cysteine added variants of interleukin-3 and chemical modifications thereof
|
|
DK168302B1
(da)
|
1989-06-29 |
1994-03-07 |
Danisco |
Fremgangsmåde til indføring af molekyler, især genetisk materiale i planteceller
|
|
DE10399023I2
(de)
|
1989-09-12 |
2006-11-23 |
Ahp Mfg B V |
TFN-bindende Proteine
|
|
US5350836A
(en)
*
|
1989-10-12 |
1994-09-27 |
Ohio University |
Growth hormone antagonists
|
|
US5225212A
(en)
|
1989-10-20 |
1993-07-06 |
Liposome Technology, Inc. |
Microreservoir liposome composition and method
|
|
EP0550629A1
(en)
|
1990-08-17 |
1993-07-14 |
Genentech, Inc. |
Metal ion mediated receptor binding of polypeptide hormones
|
|
US5206161A
(en)
|
1991-02-01 |
1993-04-27 |
Genentech, Inc. |
Human plasma carboxypeptidase B
|
|
WO1992017200A2
(en)
|
1991-03-28 |
1992-10-15 |
Genentech, Inc. |
Stable growth hormone metal ion formulations
|
|
WO1993000109A1
(en)
|
1991-06-28 |
1993-01-07 |
Genentech, Inc. |
Method of stimulating immune response using growth hormone
|
|
AU6048294A
(en)
|
1992-11-25 |
1994-06-22 |
Amgen Boulder Inc. |
Modified insulin-like growth factors
|
|
JPH08508296A
(ja)
|
1993-04-07 |
1996-09-03 |
アムジエン・ブルダー・インコーポレーテッド |
インシュリン様成長因子結合タンパク質の使用方法
|
|
EP0730660A4
(en)
*
|
1993-10-29 |
1998-02-25 |
Incyte Pharma Inc |
CHIMEAN PROTEINE PROTEASE NEXIN-1 CONTAINING VARIANTS
|
|
KR101004174B1
(ko)
|
1995-06-29 |
2010-12-24 |
임뮤넥스 코포레이션 |
세포소멸을 유도하는 시토킨
|
|
US6284236B1
(en)
|
1995-06-29 |
2001-09-04 |
Immunex Corporation |
Cytokine that induces apoptosis
|
|
DE851925T1
(de)
|
1995-09-21 |
2003-08-14 |
Genentech Inc., San Francisco |
Varianten des menschlichen wachstumshormons
|
|
US6030945A
(en)
|
1996-01-09 |
2000-02-29 |
Genentech, Inc. |
Apo-2 ligand
|
|
BR9612752A
(pt)
|
1996-10-25 |
2000-01-18 |
Human Genome Sciences Inc |
Neutrocina
|
|
WO1998028424A2
(en)
|
1996-12-23 |
1998-07-02 |
Immunex Corporation |
Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
|
|
ATE362982T1
(de)
|
1997-01-28 |
2007-06-15 |
Human Genome Sciences Inc |
ßDEATH-DOMAINß-ENTHALTENDER REZEPTOR 4 (DR4), EIN MITGLIED DER TNF-REZEPTOR SUPERFAMILIE, WELCHER AN TRAIL (APO-2L) BINDET
|
|
EP1017794A1
(en)
|
1997-02-06 |
2000-07-12 |
Novo Nordisk A/S |
Polypeptide-polymer conjugates having added and/or removed attachment groups
|
|
US6072047A
(en)
|
1997-02-13 |
2000-06-06 |
Immunex Corporation |
Receptor that binds trail
|
|
US20010010924A1
(en)
|
1997-03-14 |
2001-08-02 |
Keith Charles Deen |
Tumor necrosis factor related receptor, tr6 polynecleotides
|
|
NZ337795A
(en)
|
1997-03-17 |
2001-06-29 |
Human Genome Sciences Inc |
Death domain containing receptor 5 and it's use in the treatment of DR5 related disease
|
|
CA2287085A1
(en)
|
1997-04-16 |
1998-10-22 |
Millennium Biotherapeutics, Inc. |
Tumor necrosis factor receptor related proteins tango-63d and tango-63e
|
|
BR9808545A
(pt)
|
1997-04-16 |
2000-05-23 |
Amgen Inc |
ácido nucleico isolado, vetor de expressão, célula hospedeira, processos para produzir uma proteìna de ligação da osteoprotegerina, para detectar a presença de uma proteìna de ligação à osteoprotegerina em uma amostra biológica, para avaliar a capacidade de um composto candidato de ligar-se a uma proteìna de ligação da osteoprotegerina e de um composto de teste para aumentar ou reduzir a ligação da proteìna de ligação da osteoprotegerina a odar, para regular a expressão de uma proteìna de ligação da osteoprotegerina em um animal e para prevenir ou tratar de doença óssea em um mamìfero, polipeptìdeo, protéina de ligação da osteroprotegerina purificada e isolada, ou seu fragmento, análogo ou derivado, e, anticorpo ou seu fragmento
|
|
ES2293682T5
(es)
|
1997-05-15 |
2011-11-17 |
Genentech, Inc. |
Anticuerpo anti-apo2.
|
|
US6342369B1
(en)
|
1997-05-15 |
2002-01-29 |
Genentech, Inc. |
Apo-2-receptor
|
|
WO1999002653A1
(en)
|
1997-07-11 |
1999-01-21 |
Trustees Of The University Of Pennsylvania |
Nucleic acid encoding a novel chemotherapy-induced protein, and methods of use
|
|
EP1012184B1
(en)
|
1997-07-14 |
2007-10-10 |
Bolder Biotechnology, Inc. |
Derivatives of growth hormone and related proteins
|
|
WO1999009165A1
(en)
|
1997-08-15 |
1999-02-25 |
Idun Pharmaceuticals, Inc. |
Trail receptors, nucleic acids encoding the same, and methods of use thereof
|
|
ES2331900T3
(es)
|
1997-08-26 |
2010-01-19 |
Genentech, Inc. |
Receptor rtd.
|
|
AU9376498A
(en)
|
1997-09-05 |
1999-03-22 |
University Of Washington |
Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
|
|
JP2002508962A
(ja)
|
1998-01-15 |
2002-03-26 |
ジェネンテク・インコーポレイテッド |
Ａｐｏ−２リガンド
|
|
IL137176A0
(en)
|
1998-01-26 |
2001-07-24 |
Genentech Inc |
Antibodies to 4dr and uses thereof
|
|
PT1192185E
(pt)
|
1999-06-09 |
2006-11-30 |
Genentech Inc |
Sinergismo de agonista do receptor de apo-2l e cpt-11
|
|
US6318934B1
(en)
*
|
1999-06-24 |
2001-11-20 |
Anchor Wall Systems, Inc. |
Segmental retaining wall system
|
|
JP5118796B2
(ja)
*
|
1999-06-28 |
2013-01-16 |
ジェネンテック， インコーポレイテッド |
二価の金属イオンを利用したＡｐｏ−２リガンドの製造方法
|
|
IL153948A0
(en)
|
2000-07-27 |
2003-07-31 |
Genentech Inc |
Apo-2l receptor agonist and cpt-11 synergism
|
|
EP2348043A1
(en)
*
|
2001-10-02 |
2011-07-27 |
Genentech, Inc. |
APO-2 ligand variants and uses thereof
|